Last reviewed: May 30, 2026

Last updated: May 30, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

NAD+ (nicotinamide adenine dinucleotide) dosages in clinical practice typically range from 250 mg to 1,000 mg daily, depending on individual baseline levels, age, and metabolic goals. Research suggests older adults and those with metabolic dysfunction may benefit from higher dosing, but individual variation is substantial and biomarker-guided assessment is essential.

Understanding your NAD+ cost and dosing starts with knowing your baseline metabolic state. At PlexusDx, we emphasize precision wellness—matching supplement strategy to your individual biomarker profile and genetic predispositions. This personalized approach can help clarify whether and how NAD+ supplementation fits into your broader metabolic health plan.

Why NAD+ Cost and Dosing Vary Widely

NAD+ supplementation costs and dosing recommendations vary because NAD+ levels decline naturally with age, and clinical trials have used vastly different protocols. Oral NAD+ precursors (NMN, NR) range from 250–1,000 mg daily, while IV NAD+ infusions may deliver 500–2,500 mg per session. This variation reflects both individual metabolism and research uncertainty.

Baseline NAD+ levels, mitochondrial function, and metabolic health status all influence appropriate dosing. A person with low baseline NAD+ or age-related decline may show benefit at lower doses, while others may require higher amounts. Provider-guided dosing reduces guesswork and helps identify the dose threshold where benefit emerges.

NAD+ Dosing Framework: Typical Clinical Ranges and Factors

Clinical literature on NAD+ dosing reveals no universal consensus, but emerging data support dose-stratified protocols. Below is a framework providers often use to contextualize NAD+ dosing within individual patient profiles, including age, metabolic markers, and treatment goals.

Dosing Factor Typical Range or Consideration
Oral NMN or NR (daily) 250–750 mg for baseline support; 500–1,000 mg for advanced age or metabolic dysfunction
IV NAD+ infusion (per session) 500–2,500 mg; frequency varies from weekly to monthly depending on goals and tolerance
Age considerations Adults 40–60 may start at lower end; 60+ often benefit from mid-to-higher range
Baseline NAD+ level If serum NAD+ is low (<0.6 µM), higher dosing or more frequent dosing may be considered; normal is ~0.8–1.2 µM

Biomarker Assessment: The Case for Baseline Testing

Measuring baseline NAD+ levels, along with related metabolic markers (lactate, citrate, ATP-producing capacity), helps providers contextualize dosing decisions. NAD+ levels peak in the morning and decline with age, circadian rhythm disruption, and chronic metabolic stress. A single baseline measurement can anchor personalized dosing strategy.

Beyond NAD+ levels, providers assess mitochondrial function via indirect markers: lactate-to-pyruvate ratios, energy expenditure, and recovery from exercise. These biomarkers reveal whether NAD+ supplementation addresses the underlying metabolic bottleneck. Without baseline testing, dosing becomes empirical rather than evidence-informed.

Titration, Tolerability, and Who NAD+ Supplementation Is For

Most providers recommend starting NAD+ at the lower end of the dosage range (250–500 mg daily for oral forms) and titrating upward over 2–4 weeks. Common side effects—flushing, nausea, mild fatigue—often resolve with dose adjustment or timing modification. Patients with liver or kidney dysfunction should consult providers before supplementing.

NAD+ supplementation may be most appropriate for older adults (60+) with age-related metabolic decline, individuals recovering from illness or intensive training, and those with documented mitochondrial dysfunction. Pregnancy, advanced liver disease, and active infections are relative contraindications. A qualified provider can evaluate whether NAD+ fits your health profile and metabolic goals.

How PlexusDx Supports a More Personalized Approach

At PlexusDx, we recognize that NAD+ metabolism is intertwined with broader metabolic and peptide-pathway function. Our Precision Peptide Genetic Test examines genetic predispositions in key metabolic pathways (including FTO and MC4R variants) that may influence cellular energy status and mitochondrial efficiency. These genetic insights may help provide context for how your body responds to NAD+ and other metabolic supports.

While the Precision Peptide Genetic Test focuses on peptide-pathway predispositions relevant to GLP-1 and metabolic regulation, certain genetic variants can signal broader metabolic phenotypes—including those associated with NAD+-dependent processes. The test should be interpreted with a qualified healthcare provider to understand what genetic predispositions mean for your personalized health strategy, including decisions about NAD+ supplementation.

Understanding your genetic predispositions and baseline metabolic biomarkers can support a more informed conversation with your provider about whether NAD+ supplementation aligns with your metabolic health goals. PlexusDx encourages you to combine genetic insights with clinical biomarker data and provider guidance to build a truly personalized approach.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection starts at $179-$229/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Frequently Asked Questions

What is the typical cost of NAD+ supplementation?

Oral NAD+ precursors (NMN or NR) typically cost $30–$80 monthly for 250–500 mg daily dosing. IV NAD+ infusions range $200–$600 per session. Prices vary by supplier, formulation, and dosage strength.

Is there clinical evidence that NAD+ supplementation works?

Preclinical and animal studies show NAD+ supplementation improves mitochondrial function and metabolic markers. Human trials are limited but suggest potential benefits for age-related decline and muscle recovery. More large-scale randomized trials are needed.

How do I know if I need NAD+ supplementation?

Baseline NAD+ blood testing and assessment of metabolic markers help determine need. Consult a qualified provider to evaluate your age, metabolic health, energy status, and treatment goals before starting supplementation.

What are the main side effects of NAD+ dosing?

Common side effects include flushing, nausea, mild fatigue, and headache—often transient and dose-dependent. Slower titration and adjusted timing may reduce symptoms. Liver or kidney disease requires provider consultation.

Does PlexusDx offer NAD+ supplementation?

PlexusDx specializes in compounded peptide therapies (semaglutide, tirzepatide) and the Precision Peptide Genetic Test. We recommend consulting your provider about NAD+ and complementary metabolic supports aligned with your genetic and biomarker profile.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves